Matthew David
2020
In 2020, Matthew David earned a total compensation of $1.1M as Chief Financial Officer at CorMedix.
Compensation breakdown
| Non-Equity Incentive Plan | $99,000 |
|---|---|
| Option Awards | $768,386 |
| Salary | $209,423 |
| Other | $20,866 |
| Total | $1,097,675 |
David received $768.4K in option awards, accounting for 70% of the total pay in 2020.
David also received $99K in non-equity incentive plan, $209.4K in salary and $20.9K in other compensation.
Rankings
In 2020, Matthew David's compensation ranked 8,242nd out of 13,090 executives tracked by ExecPay. In other words, David earned more than 37.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,242 out of 13,090 | 37th |
Division Manufacturing | 3,499 out of 5,621 | 38th |
Major group Chemicals And Allied Products | 1,412 out of 2,254 | 37th |
Industry group Drugs | 1,229 out of 1,954 | 37th |
Industry Pharmaceutical Preparations | 911 out of 1,459 | 38th |
Source: SEC filing on October 29, 2021.
David's colleagues
We found five more compensation records of executives who worked with Matthew David at CorMedix in 2020.
2020
Khoso Baluch
CorMedix
Chief Executive Officer
2020
Phoebe Mounts
CorMedix
General Counsel
2020
Elizabeth Masson-Hurlburt
CorMedix
Executive Vice President and Head of Clinical Operations
2020
John Armstrong
CorMedix
Executive Vice President for Technical Operations
2020
Robert Cook
CorMedix